Related Experiment Video
Updated: Jun 10, 2025

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
434
Brain Stimulation in Alzheimer's Disease Trials
Alberto Benussi1,2, Barbara Borroni1,2
1Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Journal of Alzheimer'S Disease : JAD
|October 18, 2024
Summary
Investigating brain stimulation for Alzheimer's disease (AD) shows promise. Techniques like deep brain stimulation (DBS) and non-invasive methods offer potential therapeutic benefits, but more research is needed for effective clinical use.
Area of Science:
- Neuroscience and Neurology
- Clinical Trials and Therapeutics
Background:
- Alzheimer's disease (AD) lacks definitive curative treatments, driving the need for novel therapeutic strategies.
- Brain stimulation techniques are emerging as potential interventions for managing AD progression and symptoms.
Purpose of the Study:
- To comprehensively review recent clinical trials on invasive and non-invasive brain stimulation for Alzheimer's disease.
- To evaluate the efficacy, safety, and applicability of techniques including Deep Brain Stimulation (DBS), repetitive Transcranial Magnetic Stimulation (rTMS), Transcranial Direct Current Stimulation (tDCS), and Transcranial Alternating Current Stimulation (tACS).
Main Methods:
- Systematic review of clinical trials investigating brain stimulation modalities for Alzheimer's disease.
- Analysis of data concerning therapeutic outcomes, adverse events, and patient-specific factors.
Main Results:
- Deep Brain Stimulation (DBS) shows potential in slowing cognitive decline but carries surgical risks.
- Non-invasive methods (rTMS, tDCS, tACS) may enhance cognition and delay progression with fewer side effects, though results vary.
- Evidence suggests an individualized approach to brain stimulation is necessary, considering disease stage and patient genetics.
Conclusions:
- Brain stimulation techniques represent a promising therapeutic avenue for Alzheimer's disease.
- Further large-scale, multi-center trials are crucial to validate findings and establish clinical guidelines.
- Continued research is imperative for a comprehensive understanding and successful clinical implementation of these interventions.
Keywords:
Alzheimer’s diseasebrain stimulationdeep brain stimulationrepetitive transcranial magnetic stimulationtranscranial alternating current stimulationtranscranial direct current stimulationMore Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Brain Imaging
212
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
212

